ONCOLYTICS BIOTECH INC
ONCY
DELAYED 1 MONTH

16 insider filings · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 11, 2026Mar 13 12:00 PMJames T. ParsonsDirector
Purchase
10,000$1.03$10.3K41,849(D)

View →

Mar 12, 2026Mar 13 12:00 PMJared KellyDirector, Chief Executive Officer
Purchase
5,050$0.96$4.8K114,050(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 1, 2026Jun 3 8:30 PMWayne PisanoDirector
Grant/Award
30,000—30,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMJonathan RigbyDirector
Grant/Award
30,000—30,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMAngela HolthamDirector
Grant/Award
30,000—30,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMJames T. ParsonsDirector
Grant/Award
30,000—30,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMKirk LookChief Financial Officer
Grant/Award
260,000—260,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMAndrew AromandoChief Business Officer
Grant/Award
260,000—260,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMJared KellyDirector, Chief Executive Officer
Grant/Award
755,000—755,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMPatricia S AndrewsDirector
Grant/Award
30,000—30,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMBernd R. SeizingerDirector
Grant/Award
30,000—30,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMAllison HagermanChief Technology Officer
Grant/Award
260,000—260,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMDeborah Margaret BrownDirector
Grant/Award
30,000—30,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMThomas Charles HeinemanChief Medical Officer
Grant/Award
260,000—260,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMJohn Bearden McadoryChief Operating Officer
Grant/Award
145,000—145,000(D)

View →

Jun 1, 2026Jun 3 8:30 PMGlover Stephen C.Director
Grant/Award
96,000—96,000(D)

View →